Suppr超能文献

癌症中的长链非编码RNA:从功能到转化

Long noncoding RNAs in cancer: from function to translation.

作者信息

Sahu Anirban, Singhal Udit, Chinnaiyan Arul M

机构信息

Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan USA. ; Department of Pathology, University of Michigan, Ann Arbor, Michigan USA.

Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan USA. ; Howard Hughes Medical Institute, University of Michigan, Ann Arbor, Michigan USA.

出版信息

Trends Cancer. 2015 Oct 1;1(2):93-109. doi: 10.1016/j.trecan.2015.08.010.

Abstract

While our understanding of the molecular mechanisms underlying cancer has significantly improved, most of our knowledge focuses on protein-coding genes that make up a fraction of the genome. Recent studies have uncovered thousands of long noncoding RNAs (lncRNAs) that populate the cancer genome. A subset of these molecules shows striking cancer- and lineage-specific expression patterns, suggesting they may be potential drivers of cancer biology and have utility as clinical biomarkers. Here, we discuss emerging modalities of lncRNA biology and their interplay with cancer-associated concepts, including epigenetic regulation, DNA damage and cell cycle control, microRNA silencing, signal transduction pathways, and hormone-driven disease. Additionally, we highlight the translational impact of lncRNAs, tools for their mechanistic investigation, and directions for future lncRNA research.

摘要

虽然我们对癌症潜在分子机制的理解有了显著提高,但我们的大部分知识都集中在构成基因组一部分的蛋白质编码基因上。最近的研究发现了数千种存在于癌症基因组中的长链非编码RNA(lncRNA)。这些分子中的一部分显示出显著的癌症和谱系特异性表达模式,表明它们可能是癌症生物学的潜在驱动因素,并具有作为临床生物标志物的用途。在这里,我们讨论lncRNA生物学的新兴模式及其与癌症相关概念的相互作用,包括表观遗传调控、DNA损伤和细胞周期控制、微小RNA沉默、信号转导途径以及激素驱动的疾病。此外,我们强调lncRNA的转化影响、其机制研究的工具以及未来lncRNA研究的方向。

相似文献

1
Long noncoding RNAs in cancer: from function to translation.
Trends Cancer. 2015 Oct 1;1(2):93-109. doi: 10.1016/j.trecan.2015.08.010.
2
LncRNAs with miRNAs in regulation of gastric, liver, and colorectal cancers: updates in recent years.
Appl Microbiol Biotechnol. 2019 Jun;103(12):4649-4677. doi: 10.1007/s00253-019-09837-5. Epub 2019 May 6.
3
Long non-coding RNAs: From disease code to drug role.
Acta Pharm Sin B. 2021 Feb;11(2):340-354. doi: 10.1016/j.apsb.2020.10.001. Epub 2020 Oct 10.
4
The Interplay between Long Noncoding RNAs and Proteins of the Epigenetic Machinery in Ovarian Cancer.
Cancers (Basel). 2020 Sep 21;12(9):2701. doi: 10.3390/cancers12092701.
7
Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability.
Drug Resist Updat. 2022 Dec;65:100866. doi: 10.1016/j.drup.2022.100866. Epub 2022 Sep 20.
8
Long noncoding RNA in prostate, bladder, and kidney cancer.
Eur Urol. 2014 Jun;65(6):1140-51. doi: 10.1016/j.eururo.2013.12.003. Epub 2013 Dec 14.
9
Current concepts of the crosstalk between lncRNA and E2F1: shedding light on the cancer therapy.
Front Pharmacol. 2024 Jul 25;15:1432490. doi: 10.3389/fphar.2024.1432490. eCollection 2024.
10
Comprehensive expression genome-wide association study of long non-coding RNAs in four porcine tissues.
Genomics. 2025 May;117(3):111026. doi: 10.1016/j.ygeno.2025.111026. Epub 2025 Mar 4.

引用本文的文献

1
Epigenetic modifications in follicular cell-derived thyroid cancer: new dimensions in pathogenesis and treatment.
Front Oncol. 2025 May 20;15:1549477. doi: 10.3389/fonc.2025.1549477. eCollection 2025.
2
Landscape of lncRNAs expressed in Mexican patients with triple‑negative breast cancer.
Mol Med Rep. 2025 Jun;31(6). doi: 10.3892/mmr.2025.13528. Epub 2025 Apr 11.
4
Investigating the role of exosomal long non-coding RNAs in drug resistance within female reproductive system cancers.
Front Cell Dev Biol. 2025 Jan 24;13:1485422. doi: 10.3389/fcell.2025.1485422. eCollection 2025.
6
Beyond traditional translation: ncRNA derived peptides as modulators of tumor behaviors.
J Biomed Sci. 2024 Jun 14;31(1):63. doi: 10.1186/s12929-024-01047-0.
8
Surmounting Cancer Drug Resistance: New Perspective on RNA-Binding Proteins.
Pharmaceuticals (Basel). 2023 Aug 7;16(8):1114. doi: 10.3390/ph16081114.
10
MGCG regulates glioblastoma tumorigenicity via hnRNPK/ATG2A and promotes autophagy.
Cell Death Dis. 2023 Jul 17;14(7):443. doi: 10.1038/s41419-023-05959-x.

本文引用的文献

1
The lncRNA MIR31HG regulates p16(INK4A) expression to modulate senescence.
Nat Commun. 2015 Apr 24;6:6967. doi: 10.1038/ncomms7967.
2
Integrative genomic analysis reveals widespread enhancer regulation by p53 in response to DNA damage.
Nucleic Acids Res. 2015 May 19;43(9):4447-62. doi: 10.1093/nar/gkv284. Epub 2015 Apr 16.
5
Structural imprints in vivo decode RNA regulatory mechanisms.
Nature. 2015 Mar 26;519(7544):486-90. doi: 10.1038/nature14263. Epub 2015 Mar 18.
7
The long non-coding RNA PCGEM1 is regulated by androgen receptor activity in vivo.
Mol Cancer. 2015 Feb 21;14:46. doi: 10.1186/s12943-015-0314-4.
8
The lncRNA DRAIC/PCAT29 Locus Constitutes a Tumor-Suppressive Nexus.
Mol Cancer Res. 2015 May;13(5):828-38. doi: 10.1158/1541-7786.MCR-15-0016-T. Epub 2015 Feb 20.
9
Novel long non-coding RNAs are specific diagnostic and prognostic markers for prostate cancer.
Oncotarget. 2015 Feb 28;6(6):4036-50. doi: 10.18632/oncotarget.2879.
10
Long noncoding RNA CCAT2 correlates with smoking in esophageal squamous cell carcinoma.
Tumour Biol. 2015 Jul;36(7):5523-8. doi: 10.1007/s13277-015-3220-x. Epub 2015 Feb 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验